These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28339182)

  • 21. The impact of silver nanoparticles on microbial communities and antibiotic resistance determinants in the environment.
    Yonathan K; Mann R; Mahbub KR; Gunawan C
    Environ Pollut; 2022 Jan; 293():118506. PubMed ID: 34793904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of bacterial motility in differential resistance mechanisms of silver nanoparticles and silver ions.
    Stabryla LM; Johnston KA; Diemler NA; Cooper VS; Millstone JE; Haig SJ; Gilbertson LM
    Nat Nanotechnol; 2021 Sep; 16(9):996-1003. PubMed ID: 34155383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The activity of silver nanoparticles (Axonnite) on clinical and environmental strains of Acinetobacter spp.
    Łysakowska ME; Ciebiada-Adamiec A; Klimek L; Sienkiewicz M
    Burns; 2015 Mar; 41(2):364-71. PubMed ID: 25145873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fabrication, characterization of chitosan/nanosilver film and its potential antibacterial application.
    Thomas V; Yallapu MM; Sreedhar B; Bajpai SK
    J Biomater Sci Polym Ed; 2009; 20(14):2129-44. PubMed ID: 19874682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New Antivirals and Antibacterials Based on Silver Nanoparticles.
    Ciriminna R; Albo Y; Pagliaro M
    ChemMedChem; 2020 Sep; 15(17):1619-1623. PubMed ID: 32657536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silver nanoparticles: A new view on mechanistic aspects on antimicrobial activity.
    Durán N; Durán M; de Jesus MB; Seabra AB; Fávaro WJ; Nakazato G
    Nanomedicine; 2016 Apr; 12(3):789-799. PubMed ID: 26724539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silver nanoparticles functionalized with ampicillin.
    Rogowska A; Rafińska K; Pomastowski P; Walczak J; Railean-Plugaru V; Buszewska-Forajta M; Buszewski B
    Electrophoresis; 2017 Nov; 38(21):2757-2764. PubMed ID: 28704596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial activity of fluorescent Ag nanoparticles.
    Bera RK; Mandal SM; Raj CR
    Lett Appl Microbiol; 2014 Jun; 58(6):520-6. PubMed ID: 24460988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial activity of biogenic silver nanoparticles, and silver chloride nanoparticles: an overview and comments.
    Durán N; Nakazato G; Seabra AB
    Appl Microbiol Biotechnol; 2016 Aug; 100(15):6555-6570. PubMed ID: 27289481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial potential of commercial silver nanoparticles and the characterization of their physical properties toward probiotic bacteria isolated from fermented milk products.
    Mikiciuk J; Mikiciuk E; Wrońska A; Szterk A
    J Environ Sci Health B; 2016; 51(4):222-9. PubMed ID: 26766747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silver in medicine: the basic science.
    Marx DE; Barillo DJ
    Burns; 2014 Dec; 40 Suppl 1():S9-S18. PubMed ID: 25418438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria.
    Rai MK; Deshmukh SD; Ingle AP; Gade AK
    J Appl Microbiol; 2012 May; 112(5):841-52. PubMed ID: 22324439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphology and antibacterial activity of carbohydrate-stabilized silver nanoparticles.
    Valodkar M; Bhadoria A; Pohnerkar J; Mohan M; Thakore S
    Carbohydr Res; 2010 Aug; 345(12):1767-73. PubMed ID: 20591419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycosynthesis of silver and gold nanoparticles: Optimization, characterization and antimicrobial activity against human pathogens.
    Balakumaran MD; Ramachandran R; Balashanmugam P; Mukeshkumar DJ; Kalaichelvan PT
    Microbiol Res; 2016 Jan; 182():8-20. PubMed ID: 26686609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substrate independent silver nanoparticle based antibacterial coatings.
    Taheri S; Cavallaro A; Christo SN; Smith LE; Majewski P; Barton M; Hayball JD; Vasilev K
    Biomaterials; 2014 May; 35(16):4601-9. PubMed ID: 24630091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibacterial activity of nanosilver ions and particles.
    Sotiriou GA; Pratsinis SE
    Environ Sci Technol; 2010 Jul; 44(14):5649-54. PubMed ID: 20583805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of E. coli inhibition by plain and polymer-coated silver nanoparticles.
    Ashmore D; Chaudhari A; Barlow B; Barlow B; Harper T; Vig K; Miller M; Singh S; Nelson E; Pillai S
    Rev Inst Med Trop Sao Paulo; 2018; 60():e18. PubMed ID: 29694600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do physico-chemical properties of silver nanoparticles decide their interaction with biological media and bactericidal action? A review.
    Pareek V; Gupta R; Panwar J
    Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():739-749. PubMed ID: 29853145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The biological effects and possible modes of action of nanosilver.
    Völker C; Oetken M; Oehlmann J
    Rev Environ Contam Toxicol; 2013; 223():81-106. PubMed ID: 23149813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical synthesis and characterization of chitosan/silver nanocomposites films and their potential antibacterial activity.
    Shah A; Hussain I; Murtaza G
    Int J Biol Macromol; 2018 Sep; 116():520-529. PubMed ID: 29758310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.